Clinical Trial

Improved Medication and Care to Achieve Lipid Targets After Carotid Surgery

Study acronym: IMACS
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated June 2026 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to find out if patients who receive extra support stay on their cholesterol-lowering therapy and therefore have lower cholesterol levels after 4 months. Extra support means regular phone calls and close monitoring before and after carotid artery surgery. The study compares this approach to usual care. Participants will: Be randomly assigned to either standard care or extra support for 4 months. Receive cholesterol-lowering treatment and attend follow-up visits.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-07-03.
Trial Details
NCT Number NCT07064135
Lead Sponsor Barmherzige Brüder Linz
Collaborators: Johannes Kepler University of Linz
Conditions Dyslipidaemias, Carotid Artery Stenoses
Enrollment 50 participants
Start Date 2025-08-04
Primary Completion 2026-06 (estimated)
Study Completion 2026-12 (estimated)
Updated on ClinicalTrials.gov 2025-08-07